<html>
<head>PUBMED IDs for AEZ</head>
<body bgcolor='#C5F0F2'><h1>AEZ</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19524629/'>Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162.</a> November 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21331448/'>Targeted chemotherapy for triple-negative breast cancers via LHRH receptor.</a> August 30  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22824624/'>Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108].</a> March 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23518876/'>Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.</a> October 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23518821/'>Single nucleotide polymorphism in toll-like receptor 6 is associated with a decreased risk for ureaplasma respiratory tract colonization and bronchopulmonary dysplasia in preterm infants.</a> May 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23518807/'>Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.</a> November 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23518806/'>Association between the PTPN2 gene and Crohn's disease: dissection of potential causal variants.</a> November 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23518792/'>The effect of FXIII-A Val34Leu genotype on the risk of peripheral arterial disease.</a> August 31  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23518772/'>Biomechanical properties and correlation with collagen solubility profile in the posterior sclera of canine eyes with an ADAMTS10 mutation.</a> June 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23744510/'>Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108.</a> February 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25293576/'>Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).</a> June 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25293557/'>Germline TP53 mutations is common in patients with two early-onset primary malignancies.</a> January 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25293556/'>Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution.</a> June 27  2014<br></body></html>
